Argint International

Budapest, Hungary Founded: 2006 • Age: 20 yrs Acquired By Precision Medicine Group
Full-service regional CRO offering its services mainly to small and medium sized pharma and biotech companies

About Argint International

Argint International is a Healthcare company based in Budapest (Hungary) founded in 2006, and was acquired by Precision Medicine Group in September 2018. Full-service regional CRO offering its services mainly to small and medium sized pharma and biotech companies. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service.

Company details

Argint International was founded in 2006 in Budapest, Hungary, as a contract research organization focused on clinical development services from Phase I to IV trials. Operations are centered in Europe, with emphasis on Central and Eastern Europe. Services encompass feasibility studies, project management, monitoring, regulatory affairs, data management, biostatistics, medical writing, pharmacovigilance, and quality assurance. Therapeutic areas covered include CNS, oncology, cardiology, diabetes, and others.

Key Metrics

Investors in Argint International

Argint International has secured backing from 1 investor. Prominent investors backing the company include Precision Medicine Group.

All
InvestorDescriptionFounded YearDomainLocation
Provider of clinical research, development, and commercialization services for life sciences
2012precisionmedicinegrp.comBethesda, United States
Premium access

Investor details for Argint International

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Argint International

2 dated milestones of Argint International across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Argint International is founded.
  2. Exit Acquired by Precision Medicine Group.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Argint International

Premium access

Complete news archive for Argint International

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Argint International

Argint International was founded in 2006.

Argint International is headquartered in Budapest, Hungary.

Argint International was founded in 2006 in Budapest, Hungary, as a contract research organization focused on clinical development services from Phase I to IV trials. Operations are centered in Europe, with emphasis on Central and Eastern Europe. Services encompass feasibility studies, project management, monitoring, regulatory affairs, data management, biostatistics, medical writing, pharmacovigilance, and quality assurance. Therapeutic areas covered include CNS, oncology, cardiology, diabetes, and others.

Argint International has 1 investor. Key investors include Precision Medicine Group.

Yes. Argint International was acquired by Precision Medicine Group in September 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available